Janssen-Cilag International withdraws application for Velcade (bortezomib)
At the time of the withdrawal the application was under review by the Agency’s Committee for Medicinal Products for Human Use
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Eight potential osteoarthritis susceptibility genes discovered
It brings the total number of osteoarthritis susceptibility genes isolated in European populations to 11
Ernst & Young’s Beyond Borders 2012 report to be launched in India soon
Highlights open learning networks as the drug development model of the future
EXPAND trial of Erbitux in advanced gastric cancer does not meet primary endpoint
Erbitux in combination with cisplatin and capecitabine does not significantly increase progression-free survival in patients with…
Provepharm signs three new distribution agreements in Europe
Agreement will cover eight additional European countries
Lupin receives FDA approval for generic Ortho Tri-cyclen Lo tablets
Lupin's subsidiary, Lupin Pharmaceuticals has received approval for its Norgestimate and Ethinyl Estradiol tablets, 0.18 mg/0.025…
Serum Institute of India acquires Bilthoven Biologicals
Serum Institute will get access to technology and expertise for making injectable polio vaccine Serum Institute of India, the…
GSBTM to award biotech entrepreneurs
Biotechnopreneur Programme Awards will be followed by DBT sponsored workshops at Ahmedabad Gujarat will award some of the best…
Ecobliss India bags three awards for packaging
It has won the awards for new packaging products like LED lamps, agriculture seeds and innovative lighting Ecobliss India's all…
Frank Pieters joins Cipla
He has been appointed as Head of European Region and Global Respiratory Business Cipla has appointed Frank Pieters as the Head of…